Astrocyte-derived complement C3 facilitated microglial phagocytosis of synapses in Staphylococcus aureus-associated

Haifang Zhang1,2, Qiyuan Jin1, Jijie Li1

  • 1Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, China.

Plos Pathogens
|April 28, 2025
PubMed

Insights

Staphylococcus aureus brain infections cause cognitive impairment by activating microglia and astrocytes. Blocking complement C3 signaling can prevent synapse loss and improve cognitive function, offering therapeutic targets for brain infections.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Pathogen-induced brain infections can lead to neuronal damage and cognitive dysfunction.
  • The precise mechanisms linking infections to neurological deficits, particularly synapse loss, remain unclear.

Purpose of the Study:

  • To investigate the role of microglia and astrocytes in Staphylococcus aureus-induced cognitive impairment.
  • To elucidate the signaling pathways involved in synapse loss during S. aureus brain infections.

Main Methods:

  • Establishment of a Staphylococcus aureus mouse model to study brain infection.
  • Transcriptional profiling of microglia to identify molecular pathways.
  • Analysis of complement system involvement, specifically C1q and C3.
  • Assessment of synapse loss and cognitive function following C3-C3aR axis blockade.

Main Results:

  • S. aureus infection induced microglia and astrocyte activation, neuronal damage, synapse loss, and cognitive impairment.
  • Microglia displayed altered phagosome activity and neurogenesis regulation.
  • Complement C3, released by astrocytes, was found to activate microglia, leading to synapse phagocytosis.
  • Blocking the C3-C3aR axis mitigated microglial phagocytosis, preserved synapses, and rescued cognitive deficits.

Conclusions:

  • S. aureus triggers synapse elimination and cognitive impairment via C3-C3aR-mediated crosstalk between astrocytes and microglia.
  • This study reveals a complement-driven mechanism underlying post-infectious synapse loss and cognitive dysfunction.
  • Targeting the C3-C3aR pathway presents a potential therapeutic strategy for managing S. aureus-associated neurological complications.